Navigation Links
GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
Date:5/18/2009

onic (long-term) infection.(6) Worldwide, one million people die each year from the virus - that's nearly two people a minute.(2)

Dr Jane Zuckerman, University College London Medical School, comments: "Hepatitis B is a devastating disease and unfortunately many people have it without knowing about it. It is a silent killer that can lead to liver cancer. It is essential to protect your health by getting appropriate travel health advice and vaccinations before embarking on your trip. Make sure you don't become infected and get travel health advice and vaccinations as soon as you have booked your holiday."

Hepatitis B is a serious but preventable infectious disease. The virus can survive for up to a week in dried blood and body fluids and just a tiny cut or scratch can let it into the body where it can infect the liver.(7) Hepatitis B can be easily prevented by getting vaccinated well before the departure date. Vaccination is very effective in preventing hepatitis B and can provide travellers with peace of mind for many holidays to come.

Notes to editors
The survey
The online survey was conducted by www.OnePoll.com on behalf of GlaxoSmithKline (www.vaccines.co.uk) during April 2009. The survey was completed by 3,000 travellers. 1,897 visited destinations in the last five years where levels of hepatitis B are considered intermediate and high by the World Health Organisation. These respondents were questioned further.

Hepatitis B

 
  • Hepatitis B
    '/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3 4 5

Related medicine news :

1. Research Findings on Nine GlaxoSmithKline Cancer Compounds to be Presented at ASCO 2009
2. GlaxoSmithKline to Divest US Rights for Wellbutrin XL(R) to Biovail for $510 Million
3. GlaxoSmithKline Update: Influenza A (H1N1)
4. GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
5. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
6. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
7. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
8. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
9. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
10. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
11. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
GlaxoSmithKline Travel Health: 55 percent of travellers needlessly put themselves at risk from a potentially fatal virus
(Date:11/22/2009)... WASHINGTON, D.C. November 18, 2009 -- When peopl...parasites, which enter the body from the saliva of...pread to red blood cells. Inside the blood cells, ...dhesive proteins on the cell surface that change t.... , Experiments show that infected red blood cel...
(Date:11/22/2009)... HealthSmart, an innovative...nced that it has successfully completed a recapita...ompany’s other lenders. Silver Point Capita...nwich, Connecticut. This recapitalization allows ...ts business strategy. , , ...
(Date:11/21/2009)..., , WASHINGTON, Nov. 21 /PRNewswire-USNewswi... statement after the Senate voted to begin full de..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...ther historic step on the road to enacting health ...l hurdle, senators will now have an opportunity to...
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswire-...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test Test,Test Test Test T... More test More test More test More test More ...test More test More test More test More test More,...
(Date:11/21/2009)... New Haven Dental Group mer... D.D.S of Branford, CT. , ... Group, comprised of partners Dr. David Gibson, Dr... Forrester has just merged their growing practice ...man., , ,When Dr. Pickman decided he wanted to ret...
Breaking Medicine News(10 mins):Health News:Measuring and modeling blood flow in malaria 2Health News:HealthSmart Completes Recapitalization to Support Continued Growth, Daniel D. Crowley Named Chairman 2Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:New Haven Dental Group Expands Their Vision 2
...mory Crawford Long Hospital is the only site in th...rtain voice disorders that in the past might have...sium-titanyl-phosphate (KTP) laser, the device use...ews for those singers, teachers, lawyers and const...
...ealth authorities in the US are worried about yet ...squito-spread infection. Rudy Bueno, the Ch...aid that the situation may worsen if people don't ...pellants or going out at night in short-sleeve shi...
...ark Ridge, Ill. "Every second counts for anesthesi... known as malignant hyperthermia (MH)." Accordin...of the American Association of Nurse Anesthetists,...t is used to prepare the DS for use. Malig...
...ouths who receive more than 10 a week in spending ...likely to become 'problem drinkers', a survey of ...is from Liverpool John Moores University and colle...ing alcohol, of which 38% binged, 24% drank freque...
...mmonia gas leaked from the state-owned Fertilisers...al near here late Thursday, causing breathing pro...r the leak had been rectified. FACT offici...reathe. TV reporters who arrived at the sc...
...eople who use Swedish moist snuff (snus) run twice...is is the main result of a follow-up study conduct...lmost 300,000 male construction workers. The study...is an unusually malignant form of the disease. Sin...
Other Medicine News:Health News:New Laser Offers Alternative to Surgery in Treating Voice Disorders 2Health News:Health Authorities Fear West Nile Season Again in US 2Health News:Research Reveals Way to Speed Up Treatment of Deadly Malignant Hyperthermia 2Health News:Use of Swedish 'snus' is Linked to a Doubled Risk of Pancreatic Cancer 2
(Date:11/20/2009)...wswire/ -- Reportlinker.com announces that a new m...e. ,, Pipettes & Pipettors - A Global Mark...m/p0164373/Pipettes--Pipettors---A-Global-Market-P...um=pr&utm_campaign=prnewswire ,, Pipettes...any research laboratory. Large-scale applications ...
(Date:11/20/2009)...Nov. 20 Boston Scientifi...it has received 510(k) clearance from the U.S. Foo...al to market its WallFlex® Fully Covered Esop...geal strictures (obstructions) caused by tumors in...geal cancer. ,, (Photo: http://www.newscom.c...
(Date:11/20/2009)...Newswire-FirstCall/ -- Smith & Nephew ( SNN, L...ce the signing of a technology development contrac...t may lead to the creation of a fracture fixation ...the limbs of soldiers who sustain battlefield inju...ch Projects Agency (DARPA), the central research a...
Breaking Medicine Technology:Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 2Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 3Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 4Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 5Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 6Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 7Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 8Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 9Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 10Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 11Reportlinker Adds Pipettes & Pipettors - A Global Market Perspective 12Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 2Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 3Boston Scientific Announces FDA Clearance and CE Mark for WallFlex(R) Fully Covered Esophageal Stent 4Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 1Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 2Red Reflex Vision Exam Should Be Given to All Newborns Report Recommends 60862 3Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 1Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 2Seven LWW Nursing Editors Recognized as Leaders by American Academy of Nursing 60858 3Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 1Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 2Helix BioPharma to Present at Merriman Curhan Fords Investor Summit 2009 on November 10th 14754 3
... 2007 - ACADIA Pharmaceuticals,Inc. (Nasdaq:ACAD) ... Phase II schizophrenia co-therapy trial with ACP-...erse agonist. The trial,evaluated ACP-103 co-thera...ommonly prescribed atypical antipsychotic drug, or.... The co-therapy,arms with ACP-103 demonstrated st...
...ire-FirstCall/ -- La Jolla,Pharmaceutical Company ... data for the Phase 3 trial of Riquent(R) (abetimu...rythematosus,("lupus" or "SLE"). The updated analy...s a definitive and significant dose response,betwe...compared,with placebo (p=0.0001). These interim da...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
...aboratories is a national reference laboratory and...rch and development. ARUP offers an extensive test...n clinical and anatomic pathology. Owned by the Un...de more than half of the nation's university teach...
Medicine Products: